We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+9.22%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$124M
AUM Growth
+$14.4M
Cap. Flow
+$8.49M
Cap. Flow %
6.84%
Top 10 Hldgs %
8.4%
Holding
601
New
263
Increased
50
Reduced
50
Closed
238

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.25M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$1.25M
3
HAE icon
Haemonetics
HAE
+$779K
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$759K
5
GDDY icon
GoDaddy
GDDY
+$694K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$858K
2
DXC icon
DXC Technology
DXC
+$821K
3
WST icon
West Pharmaceutical
WST
+$728K
4
LUV icon
Southwest Airlines
LUV
+$717K
5
HWM icon
Howmet Aerospace
HWM
+$650K

Sector Composition

Rank Sector Weight
1 Technology 15.52%
2 Industrials 13.79%
3 Consumer Discretionary 12.99%
4 Healthcare 11.5%
5 Financials 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HR
601
DELISTED
Healthcare Realty Trust Incorporated
HR
– –
-7,607
Closed -$255K
21 22 23 24
25

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q4 2019 Portfolio in Review

As of Q4 2019, Fox Run Management held 601 positions worth $124M, up 13% from $110M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Fox Run Management deployed $8.49M of net new capital in Q4 2019, opening 263 new positions and adding to 50 existing holdings. Its largest new stake was Haemonetics: 6,441 shares worth $740K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Generac Holdings, an estimated $629K trimmed.

  • Fox Run Management's largest Q4 2019 buy was Haemonetics: 6,441 shares worth $740K.
  • Fox Run Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.25M increase.
  • Fox Run Management's biggest Q4 2019 reduction was Generac Holdings, cutting an estimated $629K.
  • Fox Run Management fully exited Pfizer in Q4 2019, selling an estimated $858K.
  • Fox Run Management's ten largest holdings make up 8.4% of its $124M portfolio in Q4 2019.
  • Fox Run Management opened 263 new positions and closed 238 in Q4 2019.
  • Fox Run Management's portfolio value rose 13% quarter-over-quarter to $124M.

Based on Fox Run Management's 13F filing for Q4 2019, filed 14 Feb 2020.